CVS Stock Overview
Provides health solutions in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$53.11 |
| 52 Week High | US$74.68 |
| 52 Week Low | US$49.45 |
| Beta | 0.54 |
| 11 Month Change | -9.10% |
| 3 Month Change | 0.19% |
| 1 Year Change | -14.86% |
| 33 Year Change | -35.83% |
| 5 Year Change | -23.52% |
| Change since IPO | 10.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVS | AT Healthcare | AT Market | |
|---|---|---|---|
| 7D | 0.9% | -0.4% | 0.9% |
| 1Y | -14.9% | 8.1% | 1.5% |
Return vs Industry: CVS underperformed the Austrian Healthcare industry which returned 8.1% over the past year.
Return vs Market: CVS underperformed the Austrian Market which returned 1.5% over the past year.
Price Volatility
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | 5.9% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in AT Market | 6.3% |
| 10% least volatile stocks in AT Market | 1.8% |
Stable Share Price: CVS's share price has been volatile over the past 3 months compared to the Austrian market.
Volatility Over Time: CVS's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | J. Joyner | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVS fundamental statistics | |
|---|---|
| Market cap | €63.58b |
| Earnings (TTM) | €4.76b |
| Revenue (TTM) | €348.85b |
14.1x
P/E Ratio0.2x
P/S RatioIs CVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVS income statement (TTM) | |
|---|---|
| Revenue | US$367.25b |
| Cost of Revenue | US$316.53b |
| Gross Profit | US$50.71b |
| Other Expenses | US$45.70b |
| Earnings | US$5.02b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.99 |
| Gross Margin | 13.81% |
| Net Profit Margin | 1.37% |
| Debt/Equity Ratio | 85.4% |
How did CVS perform over the long term?
See historical performance and comparison